Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

1 paper

Chapter 1 Ibogaine: A review

This page describes ibogaine as a plant-derived psychedelic that some researchers are studying for addiction, depression, and PTSD. It says ibogaine can cause strong hallucinations that start within hours and may last up to 24 hours. The page reports some studies and a 2022 review that suggest ibogaine may reduce…

Alkaloids: synthesis and pharmacology Chemical synthesis and alkaloids Neurotransmitter Receptor Influence on Behavior
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.